Subcutaneous Delivery of Daratumumab in Relapsed or Refractory Multiple Myeloma

Saad Z. Usmani, Hareth Nahi, Maria-Victoria Mateos, Niels W.C.J. van de Donk, Ajai Chari, Jonathan L. Kaufman, Philippe Moreau, Albert Oriol, Torben Plesner, Lotfi Benboubker, Peter Hellemans, Tara Masterson, Pamela L. Clemens, Man Luo, Kevin Liu and Jesus San Miguel

Article Information


Print ISSN 
Online ISSN 
  • Submitted March 19, 2019
  • Revision received July 2, 2019
  • Accepted June 28, 2019
  • Published online July 3, 2019.

  • Saad Z. Usmani, 1Levine Cancer Institute/Atrium Health, United States
  • Hareth Nahi, 2Karolinska Institute, Department of Medicine, Division of Hematology, Karolinska University Hospital at Huddinge, Sweden
  • Maria-Victoria Mateos, 3Department of Hematology, University Hospital of Salamanca7IBSAL, Spain
  • Niels W.C.J. van de Donk, 4Hematology, VU University Medical Center, Netherlands
  • Ajai Chari, 5Mount Sinai Hospital, United States
  • Jonathan L. Kaufman, 6Hematology and Medical Oncology, Emory University Winship Cancer Institute, United States
  • Philippe Moreau, 7Department of Hematology, Centre Hospitalier Universitaire de Nantes, France
  • Albert Oriol, 8Clinical Hematology, ICO - Hosp Germans Trias i Pujol, Spain
  • Torben Plesner, 9Hematology, Vejle Hospital, Denmark
  • Lotfi Benboubker, 10Hematology & cell therapy, CHRU TOURS, France
  • Peter Hellemans, 11Janssen Research & Development, LLC, Belgium
  • Tara Masterson, 12Janssen Research & Development, LLC, United States
  • Pamela L. Clemens, 13Janssen R&D, United States
  • Man Luo, 12Janssen Research & Development, LLC, United States
  • Kevin Liu, 14Biostatistics, Johnson & Johnson PRD, LLC, United States
  • Jesus San Miguel, 15Clinica Universidad de Navarra, Universidad de Navarra, Spain Statistics

The Altmetric score is a weighted count of online attention designed to reflect the volume and reach of online engagement surrounding an individual research output